(TORC) – Hot FDA News
-
resTORbio (TORC) Announces Initiation of Study to Evaluate if Antiviral Prophylaxis with RTB101 Reduces the Severity of COVID-19 in Nursing Home Residents
-
resTORbio (TORC) Phase 3 PROTECTOR 1 Trial of RTB101 in Clinically Symptomatic Respiratory Illness Did Not Meet Primary Endpoint
Back to TORC Stock Lookup
